The US Blood Testing Market is creating new opportunities for diagnostic technology providers as demand for convenient, accurate, and accessible healthcare services increases. Market Research Future projects the market to reach USD 61.5 billion by 2035, rising from USD 29.59 billion in 2025 at a CAGR of 7.59%. Growing awareness of regular health examinations, increasing chronic disease cases, and the need for early diagnosis are encouraging the adoption of blood testing services. Complete blood counts, blood glucose tests, blood chemistry examinations, and coagulation tests remain important diagnostic procedures across healthcare settings.

Market participants are focusing on product innovation, advanced laboratory equipment, and improved testing technologies to meet changing healthcare requirements. The development of portable diagnostic devices and home-based testing kits is helping make blood testing more accessible beyond traditional healthcare facilities. Meanwhile, manufacturers are improving reagents, instruments, and software solutions to support efficient laboratory operations. Companies such as Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific continue to contribute to the competitive landscape. As healthcare technology advances, the market is expected to offer attractive opportunities for innovation and business development.

Q1. What opportunities are available in the US Blood Testing Market?

Opportunities include home-based testing kits, portable diagnostic devices, laboratory automation, advanced reagents, and personalized diagnostic solutions.

Q2. Which products are included in the blood testing market?

The market includes reagents, consumables, testing instruments, and laboratory software.

Q3. Why is home-based blood testing gaining attention?

Home-based testing offers convenience and can make certain diagnostic services more accessible to consumers.

Q4. Who are the major market participants?

Key companies include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, and Becton Dickinson.

Q5. What is the long-term outlook for the US Blood Testing Market?

The outlook remains positive, supported by increasing diagnostic requirements, technological innovation, preventive healthcare, and rising demand for advanced testing solutions.

Access detailed findings to navigate market complexities:

Small Molecule API Market Trends

Orthodontic Supplies Market Growth

Preclinical Imaging Market Demand

Multiplex Assays Market Volume

Hemophilia Treatment Market Forecast